Researchers Database

KURIHARA, Ryohsuke

  • Faculty of Medicine
  • School of Medicine
  • Assistant Professor
Last Updated :2025/04/24

Researcher Information

J-Global ID

Research Interests

  • 医用化学   生体材料   

Research Areas

  • Nanotechnology/Materials / Nanomaterials
  • Nanotechnology/Materials / Biochemistry

Academic & Professional Experience

  • 2018/12 - Today  Kagawa UniversitySchool of Medicine, Faculty of Medicine
  • 2015/09 - 2018/11  College of Science and Engineering College of Science and Engineering Department of Chemistry and Biological Science Assistant Professor
  • 2013/04 - 2015/08  Graduate School of Medicine Kyoto University Researcher
  • 2012/05 - 2013/03  Graduate School of Engineering Kyoto University Researcher

Education

  • 2004/04 - 2012/03  Kyushu University  システム生命科学府  システム生命科学専攻
  • 2000/04 - 2004/03  Chiba University  Faculty of Engineering  物質工学科

Association Memberships

  • THE JAPAN SOCIETY OF DRUG DELIVERY SYSTEM   THE CHEMICAL SOCIETY OF JAPAN   

Published Papers

Books etc

  • <注目の論文>微小ナノ粒子の新たな可能性
    (Others<注目の論文>)月刊「化学」, 化学同人, 72, 63-64 2017
  • がん治療における標的超音波造影剤によるアポトーシスの誘導
    翻訳; 栗原亮介; 監修; 川上浩司 Pharm Tech Japan, 31, 105-113 2015
  • マクロファージに対する非凝縮DNA送達およびトランスフェクションシステムとしてのアルギン酸カルシウム微粒子
    翻訳; 栗原亮介; 監修; 川上浩司 Pharm Tech Japan, 30, 65-72 2014

Conference Activities & Talks

  • 会合体形成特性を持つ両親媒性siRNAの機能評価  [Not invited]
    栗原亮介; 朝日航; 田邉一仁
    日本化学会 第98春季年会  2018/03
  • 会合体形成特性を持つ疎水性蛍光色素を備えた両親媒性核酸の開発  [Not invited]
    栗原亮介; 朝日航; 田邉一仁
    国際癌治療増感研究協会 第20回 菅原・大西記念癌増感シンポジウム  2018/02

MISC

Industrial Property Rights

  • 特開2012-001461:金ナノロッドを含有するS/O製剤  
    新留 琢郎, 新留 康郎, 神谷 典穂, 後藤 雅宏, 片山 佳樹, ダークロン・ピスワン, 野瀬 圭介, 栗原 亮介

Research Grants & Projects

  • 核酸会合体によるセラノスティクスへの応用
    日本学術振興会:科研費補助金(若手研究)
    Date (from‐to) : 2019 -2021 
    Author : 栗原 亮介
  • Study on new strategy of glioblastoma treatment by molecular targeted anti-cancer hybrid peptide
    Japan Society for the Promotion of Science:Grants-in-Aid for Scientific Research
    Date (from‐to) : 2014/04 -2017/03 
    Author : Kawakami Koji; HORIBE TOMOHISA; KOHNO MASAYUKI; KURIHARA RYOUSUKE; SETO KAHORI; ARONGGAOWA
     
    We focused on the IL-13 receptor alpha 2 (IL13Ralpha2), which plays critical and important roles in glioblastoma cells, and performed the screening binding peptide to the receptor using T7 phage display system. We successfully selected one candidate peptide binding specifically to IL13Ralpha2, and designed IL13Ra2-lytic hybrid peptide by conjugation with lytic type peptide against cancer membrane. It was found that IL13Ra2-lytic had effective cytotoxic activity against glioblastoma cell lines which express IL13Ralpha2, and the peptide had also anti-tumor activity in vivo. These results suggest that hybrid peptide designed in this study may also new candidate for the development of glioblastoma treatment in the future.
  • ハイブリッドペプチドとデンドリマーを組合わせた難治性癌に対する新規抗癌剤の開発
    日本学術振興会:科研費補助金(若手研究B)
    Date (from‐to) : 2014 -2016 
    Author : 栗原 亮介

Social Contribution

  • おもしろワクワク化学の世界 '21香川化学展―オンライン開催―
    Date (from-to) : 2021/08/07-2021/08/08
    Role : Organizing member
    Sponser, Organizer, Publisher  : 日本化学会中国四国支部
  • おもしろワクワク化学の世界 '19香川化学展
    Date (from-to) : 2019/08/03-2019/08/04
    Role : Organizing member
    Sponser, Organizer, Publisher  : 日本化学会中国四国支部
  • 細胞のなかを見てみよう
    Date (from-to) : 2017/08/01
    Role : Lecturer
    Sponser, Organizer, Publisher  : 相模原市 町田市
    Event, Program, Title : さがまちカレッジ


Copyright © MEDIA FUSION Co.,Ltd. All rights reserved.